
Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
Author(s) -
Feng Duan,
Yanhua Bai,
Li Cui,
Xiaohui Li,
Jieyu Yan,
Maoqiang Wang
Publication year - 2020
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v12.i1.92
Subject(s) - medicine , radiofrequency ablation , hepatocellular carcinoma , transcatheter arterial chemoembolization , retrospective cohort study , incidence (geometry) , stage (stratigraphy) , overall survival , radiology , liver cancer , ablation , gastroenterology , surgery , paleontology , physics , optics , biology
Hepatocellular carcinoma (HCC) is a common cancer and a leading cause of tumor-related death. Patients with large HCC (≥ 8 cm) are at an advanced stage and have poor prognosis, and hepatic resection may not be suitable, and the incidence of postoperative recurrence is high.